Notably, this predictive association was robust across various subgroups, except for specific demographic and clinical parameters such as age < 58 years old, CEA ≤ 2.5 ng/mL, tumor diameter > 44.0 mm, and tumor free margin ≥ 50 mm. Here, CEACAM5 is linked to neoplasm.